Lv52
880 积分 2025-06-14 加入
What Is New in the 2025 American Thyroid Association’s Guidelines on Thyroid Cancer?
1个月前
已关闭
Complication Rates of Total Thyroidectomy vs Hemithyroidectomy for Treatment of Papillary Thyroid Microcarcinoma
1个月前
已完结
Management of Sonographically Suspicious Thyroid Nodules 1 cm or Smaller and Candidacy for Active Surveillance: Experience of a Tertiary Center in China
1个月前
已完结
Active surveillance for adult low-risk papillary thyroid microcarcinoma—a review focused on the 30-year experience of Kuma Hospital—
1个月前
已关闭
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
2个月前
已完结
Elevated thyroid‐stimulating hormone level in a euthyroid neonate caused by macro thyrotropin–IgG complex
2个月前
已完结
Anti-Thyrotropin Autoantibodies in Patients with Macro-Thyrotropin and Long-Term Changes in Macro-Thyrotropin and Serum Thyrotropin Levels
2个月前
已完结
Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025
4个月前
已关闭
NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025
4个月前
已完结
NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025
4个月前
已关闭
皖公网安备34019202002308
